Parkinson's Disease Trial, Not Yet Recruiting NCT06888869 Sponsor: Taipei Veterans General Hospital, Taiwan Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06888869
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with primary Parkinson's disease by a neurologist.
  • People whose Parkinson's disease falls within a mild to moderate range, as measured by a scale called the Modified Hoehn and Yahr Scale (stages I to III).
  • People aged between 45 and 85 years old.
  • People who score 24 or above on a standard memory and thinking test called the Mini-Mental State Examination (MMSE).
  • People whose Parkinson's disease medications have been at a stable dose (confirm with trial site for how long this must have been the case).
  • People who are able to walk 15 metres on their own or with the help of a walking aid.
  • People who are able to understand movement instructions and complete the required test activities.
  • People who are able to understand and are willing to sign an informed consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a rheumatic disease.
  • People who have an unstable heart or breathing condition, such as angina or pulmonary embolism.
  • People who have a severe or unstable neurological or bone and joint condition, such as a history of stroke, dementia, or fractures.
  • People with severe hearing or vision problems that would prevent them from working with the research team.
  • People who have been diagnosed with a mental illness.
  • People who have a personal history of epilepsy, or who have a close blood relative with a history of epilepsy.
  • People who are pregnant or breastfeeding.
  • People who have any long-term health condition that is not well controlled and may raise safety concerns.
  • People who live alone without a family member or a regular carer at home.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-966070329

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Taipei Veterans General Hospital, Taiwan
Registry
ClinicalTrials.gov
Start date
21 March 2025
Est. completion
31 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Change from Baseline Timed Up and Go test (TUG) at 12 weeks; Change from Baseline muscle strength of upper limbs at 12 weeks; Change from Baseline muscle strength of lower limbs at 12 weeks; Change from Baseline gait Speed at 12 weeks; Change from Baseline the Mini-Mental State Exam (MMSE) at 12 weeks; Change from Baseline Quality of Life Scale(PDQ39) at 12 weeks; Change from Baseline technology acceptance forms at 12 weeks; Change from Baseline The unified Parkinson's disease rating scale(UPDRS) at 12 weeks; Change from Baseline IPAQ Taiwan Activity Survey at 12 weeks; Change from Baseline Si...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov